Oncurious NV

📍 Leuven, Belgium🗓 Founded 2015💰 Last funded Mar 2015
Pharmaceutical Manufacturing🌐 oncurious.com
Website LinkedIn
Oncurious NV is a Belgium-based biotech company focused on developing innovative oncology treatments derived from a series of promising new targets that are designed to enhance T cell activity, migration and influx into resistant tumor sites, boosting the patient’s own immune response against cancer. The company's lead immuno-oncology asset is a Treg-depleting asset, targeting a protein specifically expressed on Tregs in the tumor microenvironment. The program is in lead optimization. The company's two other programs are focused on T cell migration and are in the discovery stages.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in Oncurious NV?
Oncurious NV has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Oncurious NV last raise funding?
The most recent investment in Oncurious NV recorded on gritt.io was in March 2015.
When was Oncurious NV founded?
Oncurious NV was founded in 2015.
What industry is Oncurious NV in?
Oncurious NV operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Oncurious NV based?
Oncurious NV is headquartered in Leuven, Belgium.